{"content":"<li class=\"n-box-item date-title\" data-end=\"1483765199\" data-start=\"1483678800\" data-txt=\"Sunday, December 22, 2019\">Friday, January  6, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3234003\" data-ts=\"1483744665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3234003-windstream-pushes-back-on-objections-to-dsl-shutdown-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream pushes back on objections to DSL shutdown plans</a></h4><ul>   <li>Windstream (<a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a> <font color='red'>-2.3%</font>) is facing down voices opposed to its plans to discontinue DSL service for small and medium-sized businesses, saying the objections are <a href=\"http://www.fiercetelecom.com/telecom/windstream-refutes-concerns-clec-dsl-service-shutdown-says-claims-are-unfounded\" target=\"_blank\">based on \"unfounded concerns.\"</a></li>    <li>Most commenters aren't customers and so aren't affected by the proposed shutdowns, Windstream says, adding that the plans &ldquo;would impact a small number of customers who are served on equipment that is at the end of life, no longer supported by vendors and cost-prohibitive to replace.&rdquo;</li>    <li>Some FCC commenters are incorrectly discussing a shutdown of standard wireline services rather than DSL, the company notes.</li>    <li>In November, Windstream filed an application to shut down DSL it offers to about 300 customers in 22 states due to low uptake and unsupported equipment.</li>    <li><a href=\"https://ecfsapi.fcc.gov/file/10104110593573/WC%2016-399%20Reply%20Comments_2.pdf\" target=\"_blank\">FCC filing</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3234003\" data-linked=\"Windstream pushes back on objections to DSL shutdown plans\" data-tweet=\"$WIN $WINMQ - Windstream pushes back on objections to DSL shutdown plans https://seekingalpha.com/news/3234003-windstream-pushes-back-on-objections-to-dsl-shutdown-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3234003-windstream-pushes-back-on-objections-to-dsl-shutdown-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3234002\" data-ts=\"1483744126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTX\" target=\"_blank\">PTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3234002-pernix-therapeutics-taps-pi-top-legal-exec\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pernix Therapeutics taps Piña as top legal exec</a></h4><ul>   <li>Specialty pharmaceutical firm Pernix Therapeutics (NYSEMKT:<a href='https://seekingalpha.com/symbol/PTX' title='Pernix Therapeutics Holdings, Inc.'>PTX</a>) has <a href=\"https://seekingalpha.com/pr/16707716-pernix-therapeutics-appoints-ken-pi-general-counsel-chief-compliance-officer\" target=\"_blank\">named Ken Pi&ntilde;a</a> to the posts of senior VP, general counsel and chief compliance officer.</li>    <li>Pi&ntilde;a will work as senior in-house counsel and report to CEO John Sedor.</li>    <li>Most recently he was founder and managing principal of Core Risks Ltd., acquired by Jardine Lloyd Thompson; prior to that, he served as chief legal officer at Henkel Corp.</li>    <li>Meanwhile, volume poured into shares in the afternoon as the stock <font color='green'>rose 28.7%</font> on no apparent news.</li>    <li>After hours, <a href='https://seekingalpha.com/symbol/PTX' title='Pernix Therapeutics Holdings, Inc.'>PTX</a> <font color='green'>up another 3%</font> and touching $3.02/share.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3234002\" data-linked=\"Pernix Therapeutics taps Piña as top legal exec\" data-tweet=\"$PTX $PTX-OLD - Pernix Therapeutics taps Piña as top legal exec https://seekingalpha.com/news/3234002-pernix-therapeutics-taps-pi-top-legal-exec?source=tweet\" data-url=\"https://seekingalpha.com/news/3234002-pernix-therapeutics-taps-pi-top-legal-exec\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233998\" data-ts=\"1483742780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMC\" target=\"_blank\">VMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233998-markit-forecasts-double-digit-dividend-hikes-handful-of-firms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Markit forecasts double-digit dividend hikes at handful of firms</a></h4><ul>   <li>Markit Dividend Forecasting is expecting big things from a handful of companies this quarter: namely <a href=\"http://blogs.barrons.com/incomeinvesting/2017/01/06/big-dividend-hikes-expected-from-cisco-tjx-and-home-depot\" target=\"_blank\">double-digit increases in their dividends</a>.</li>    <li>The firms aren't necessarily in the dividend-yield vanguard, but they are expected to make big increases, led by Vulcan Materials (<a href='https://seekingalpha.com/symbol/VMC' title='Vulcan Materials Company'>VMC</a> <font color='red'>-2.9%</font>) -- for which Markit is forecasting a 25% hike.</li>    <li>A 15% increase of the dividend at Cisco Systems (<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a> <font color='green'>+0.2%</font>), meanwhile, would give it the highest yield of the companies Markit discusses, at 3.9%. \"We expect Cisco Systems to increase its quarterly dividend by 15% to $0.30 in its next announcement,\" Markit says. \"The company has grown the dividend by an average of 15% resulting in an average payout ratio of 37% in the last three years.\"</li>    <li>Other double-digit increases are expected at TJX (<a href='https://seekingalpha.com/symbol/TJX' title='TJX Companies Inc.'>TJX</a> <font color='red'>-0.2%</font>), which it expects will go up by 16% to $0.30; Home Depot (<a href='https://seekingalpha.com/symbol/HD' title='Home Depot, Inc.'>HD</a> <font color='red'>-0.3%</font>), for which Markit's forecasting a near-14% increase to $0.79; and Comcast (<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='green'>+0.2%</font>), which it expects will raise to $0.31.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233998\" data-linked=\"Markit forecasts double-digit dividend hikes at handful of firms\" data-tweet=\"$VMC $VMC $CSCO - Markit forecasts double-digit dividend hikes at handful of firms https://seekingalpha.com/news/3233998-markit-forecasts-double-digit-dividend-hikes-handful-of-firms?source=tweet\" data-url=\"https://seekingalpha.com/news/3233998-markit-forecasts-double-digit-dividend-hikes-handful-of-firms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233996\" data-ts=\"1483742166\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233996-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a> <font color='green'>+4.4%</font>. <a href='https://seekingalpha.com/symbol/TAHO' title='Tahoe Resources Inc.'>TAHO</a> <font color='green'>+3.7%</font>. <a href='https://seekingalpha.com/symbol/CYBE' title='CyberOptics Corporation'>CYBE</a> <font color='green'>+2.8%</font>. <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='green'>+2.3%</font>. EBIO <font color='green'>+2.2%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/SSI' title='Stage Stores, Inc.'>SSI</a> <font color='red'>-12.5%</font>. <a href='https://seekingalpha.com/symbol/IT' title='Gartner Inc.'>IT</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/SAN' title='Banco Santander S.A.'>SAN</a> <font color='red'>-2.0%</font>. <a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='red'>-1.8%</font>. <a href='https://seekingalpha.com/symbol/LPLA' title='LPL Financial Holdings Inc.'>LPLA</a> <font color='red'>-1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233996\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$HOV $TAHO $CYBE - After Hours Gainers / Losers https://seekingalpha.com/news/3233996-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3233996-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233994\" data-ts=\"1483741400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233994-despite-end-to-promo-directv-now-still-price-foot-in-hulu-territory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Despite end to promo, DirecTV Now still has price foot in Hulu territory</a></h4><ul>   <li>Even with the upcoming end to promotional pricing at its DirecTV Now streaming service, AT&amp;T (<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='red'>-2%</font>) will still have a (smaller) $35/month package on offer -- an important note as Hulu prepares a <a href=\"https://seekingalpha.com/news/3233489-hulu-live-tv-service-under-40-coming-months\" target=\"_blank\">live TV service \"under $40.\"</a></li>    <li>While AT&amp;T's $35 price for its 100-channel DirecTV Now package reverts to $60/month on Monday, it will still offer its smallest package (60-plus channels) for $35/month -- and <a href=\"http://www.investors.com/news/technology/att-35-video-streaming-will-live-on-after-promotion-ends/\" target=\"_blank\">that's good enough for most</a>, analyst Craig Moffett notes.</li>    <li>\"Virtually all of the channels that anyone would really want, save for regional sports networks, are included in the $35 'Live a Little' package,\" Moffett says, although that package lacks America's top broadcast network -- <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a>, which sealed a deal to be <a href=\"https://seekingalpha.com/news/3233484-hulu-confirms-deal-rights-live-cbs-broadcast-two-networks\" target=\"_blank\">included in the service at Hulu</a> (<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>, <a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>, <a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>/<a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>, <a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>).</li>    <li>Stepping up to $50 a month makes sense for DirecTV Now's real sports fans, but going up to $60 or $70 per month gets users mostly a bunch of filler, Moffett says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233994\" data-linked=\"Despite end to promo, DirecTV Now still has price foot in Hulu territory\" data-tweet=\"$CBS $VIAC $CMCSA - Despite end to promo, DirecTV Now still has price foot in Hulu territory https://seekingalpha.com/news/3233994-despite-end-to-promo-directv-now-still-price-foot-in-hulu-territory?source=tweet\" data-url=\"https://seekingalpha.com/news/3233994-despite-end-to-promo-directv-now-still-price-foot-in-hulu-territory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233980\" data-ts=\"1483737228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233980-looking-to-2018-loop-raises-cbs-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Looking to 2018, Loop raises CBS price target</a></h4><ul>    <li>Loop Capital is looking ahead to 2018 when it comes to CBS (<a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> <font color='red'>-1.8%</font>), which faces a number of key catalysts in that year.</li>    <li>The coming year may be pressed due to tough comps from last year's Super Bowl broadcast, says analyst David Miller, who <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/17/01/8877218/cbs-investors-look-to-2018-this-year-will-be-a-transitio\" target=\"_blank\">foresees a 9.5% decline</a> in core Entertainment revenue.</li>    <li>He expects 2017 EPS to drop 0.3%, though three catalysts stand out for 2018: a banner international syndication year; inclusion in skinny bundles at Sling TV and DirecTV Now; and market-rate resets of about 10% of the company's retransmission fees, &ldquo;yielding 2018 as the first full year existent under those new economics.&rdquo;</li>    <li>Miller maintains a Buy rating and bumps his price target to $77 from $67, implying near-20% upside from today's close.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233980\" data-linked=\"Looking to 2018, Loop raises CBS price target\" data-tweet=\"$CBS $VIAC - Looking to 2018, Loop raises CBS price target https://seekingalpha.com/news/3233980-looking-to-2018-loop-raises-cbs-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3233980-looking-to-2018-loop-raises-cbs-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233975\" data-ts=\"1483734360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIVE\" target=\"_blank\">LIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233975-live-ventures-ceo-halts-stock-slide-250k-market-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Live Ventures CEO halts stock slide with $250K market purchase</a></h4><ul>   <li>In the face of a <a href=\"https://seekingalpha.com/news/3233923-live-ventures-minus-10-percent-short-report-charges-paid-promotion\" target=\"_blank\">short report</a> that pummeled Live Ventures (NASDAQ:<a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a>) stock, the company says its CEO Jon Isaac has <a href=\"https://seekingalpha.com/pr/16707690-live-ventures-ceo-jon-isaac-purchases-250000-company-stock-open-market\" target=\"_blank\">bought more than $250,000 worth</a> of stock on the open market.</li>    <li>That's brought a pause in the company's slide, now <font color='red'>down 9.5%</font>. It was <font color='red'>down as much as 20%</font> just before news of the purchases.</li>    <li>&ldquo;The purchase of this stock is representative of my confidence in the potential of Live Ventures stock, as well as the continued execution of its business plan,&rdquo; Isaac says in a statement.</li>    <li>Isaac bought 13,795 shares on the open market at an average price of $18.60; the stock closed yesterday at $20.67.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233975\" data-linked=\"Live Ventures CEO halts stock slide with $250K market purchase\" data-tweet=\"$LIVE - Live Ventures CEO halts stock slide with $250K market purchase https://seekingalpha.com/news/3233975-live-ventures-ceo-halts-stock-slide-250k-market-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3233975-live-ventures-ceo-halts-stock-slide-250k-market-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233974\" data-ts=\"1483734083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AES\" target=\"_blank\">AES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233974-aes-corp-starts-development-of-four-solar-pv-projects-in-california\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AES Corp. starts development of four solar PV projects in California</a></h4><ul>     <li>AES&nbsp;Corp. (<a href='https://seekingalpha.com/symbol/AES' title='The AES Corporation'>AES</a> <font color='green'>+3.6%</font>) is higher after announcing the launch of development of solar projects in California in partnership with ImMODO Energy Services.</li>     <li>The partners are starting construction of four PV projects totaling 11.3 MW located in Delano (1.4 MW), Manteca (1.3 MW) and  Bakersfield (7.1 MW and 1.5 MW), that are expected to come on line by this August, and commission a 2 MW project located in Lemoore.</li><li>AES says it has secured a 20-year power purchase agreement with  PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='green'>+1%</font>)  to provide energy for the solar program.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233974\" data-linked=\"AES Corp. starts development of four solar PV projects in California\" data-tweet=\"$AES $AES $PCG - AES Corp. starts development of four solar PV projects in California https://seekingalpha.com/news/3233974-aes-corp-starts-development-of-four-solar-pv-projects-in-california?source=tweet\" data-url=\"https://seekingalpha.com/news/3233974-aes-corp-starts-development-of-four-solar-pv-projects-in-california\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233973\" data-ts=\"1483733995\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPACE\" target=\"_blank\">SPACE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233973-spacex-gets-license-will-resume-rocket-launches-monday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SpaceX gets license, will resume rocket launches Monday</a></h4><ul>   <li>SpaceX (<a href='https://seekingalpha.com/symbol/SPACE' title='SpaceX'>SPACE</a>) has <a href=\"http://www.cnbc.com/2017/01/06/spacex-gets-faa-launch-approval-but-takeoff-postponed-until-monday.html\" target=\"_blank\">gotten the FAA license</a> for its upcoming rocket launch, though the launch has been delayed to Monday.</li>    <li>That's after the company has been sidelined since a September launch pad explosion.</li>    <li>The flight on Monday morning will carry 10 satellites set to be part of Iridium's (<a href='https://seekingalpha.com/symbol/IRDM' title='Iridium Communications Inc'>IRDM</a> <font color='red'>-2.5%</font>) \"Next\" constellation.</li>    <li>As for SpaceX's accident, \"The FAA accepted the investigation report on the AMOS-6 mishap and has closed the investigation,\" the agency said.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233973\" data-linked=\"SpaceX gets license, will resume rocket launches Monday\" data-tweet=\"$SPACE $SPACE $IRDM - SpaceX gets license, will resume rocket launches Monday https://seekingalpha.com/news/3233973-spacex-gets-license-will-resume-rocket-launches-monday?source=tweet\" data-url=\"https://seekingalpha.com/news/3233973-spacex-gets-license-will-resume-rocket-launches-monday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233972\" data-ts=\"1483733697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMI\" target=\"_blank\">MMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233972-marcus-millichap-commercial-deals-drop-thanks-to-election-rates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marcus &amp; Millichap commercial deals drop thanks to election, rates</a></h4><ul><li>Management at Marcus &amp; Millichap (<a href='https://seekingalpha.com/symbol/MMI' title='Marcus & Millichap, Inc.'>MMI</a> <font color='red'>-3.8%</font>) confirms research from William Blair suggesting the election and sharp rise in interest rates have delayed or scuttled deals across property types and sizes.</li><li>While buyers have to contend with higher interest rates, sellers - eyeing possible lower tax rates - are thinking their properties are worth more today than they were two months ago.</li><li>Blair cuts its Q4 revenue estimate for MMI to $177M from $212M, and EPS to $0.44 from $0.50. The team also cuts estimates across its commercial real estate coverage universe - JLL (<a href='https://seekingalpha.com/symbol/JLL' title='Jones Lang Lasalle Inc.'>JLL</a> <font color='red'>-0.4%</font>), CRBE (CBG <font color='red'>-1.7%</font>), Colliers International (<a href='https://seekingalpha.com/symbol/CIGI' title='Colliers International Group Inc.'>CIGI</a> <font color='red'>-0.7%</font>).</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3233972\" data-linked=\"Marcus &amp; Millichap commercial deals drop thanks to election, rates\" data-tweet=\"$MMI $MMI $JLL - Marcus &amp; Millichap commercial deals drop thanks to election, rates https://seekingalpha.com/news/3233972-marcus-millichap-commercial-deals-drop-thanks-to-election-rates?source=tweet\" data-url=\"https://seekingalpha.com/news/3233972-marcus-millichap-commercial-deals-drop-thanks-to-election-rates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233969\" data-ts=\"1483732834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233969-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ICAD' title='iCAD, Inc.'>ICAD</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/MIXT' title='MiX Telematics Limited'>MIXT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ITI' title='Iteris, Inc'>ITI</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/VRTU' title='Virtusa Corporation'>VRTU</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/EVH' title='Evolent Health'>EVH</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ATEA' title='Astea International, Inc.'>OTC:ATEA</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/EMAN' title='eMagin Corporation'>EMAN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MXPT' title='MaxPoint Interactive'>MXPT</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233969\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$ICAD $MIXT $ITI - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3233969-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3233969-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233971\" data-ts=\"1483732379\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TAHO\" target=\"_blank\">TAHO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233971-tahoe-resourcesminus-14-on-worrisome-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tahoe Resources -14% on worrisome guidance</a></h4><ul><li>Tahoe Resources (<a href='https://seekingalpha.com/symbol/TAHO' title='Tahoe Resources Inc.'>TAHO</a> <font color='red'>-14%</font>) plunges after reporting record 2016 silver and gold production but <a href=\"https://seekingalpha.com/pr/16707088-tahoe-resources-achieves-record-silver-gold-production-2016-announces-2017-financial\" target=\"_blank\">disappointing 2017 guidance</a>.</li><li>TAHO says 2016 silver production totaled a record 21.3M oz., exceeding company guidance of 18M-21M oz., while gold production came in at more than 385K oz., in-line with guidance of 370K-430K oz.</li><li>But TAHO forecasts 2017 production of 18M-21M silver oz. and 375K-425K gold oz., and project capex of $150M-$175M, with relatively high all-in sustained costs of $9.50-$10.50 per silver oz. produced and $1,150-$1,250 per gold oz. produced.</li><li>Shares had surged nearly 10% yesterday after maintaining its current dividend.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233971\" data-linked=\"Tahoe Resources -14% on worrisome guidance\" data-tweet=\"$TAHO - Tahoe Resources -14% on worrisome guidance https://seekingalpha.com/news/3233971-tahoe-resourcesminus-14-on-worrisome-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3233971-tahoe-resourcesminus-14-on-worrisome-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233964\" data-ts=\"1483731354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233964-energy-materials-top-5-gainers-losers-of-2-30-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:30 pm</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/MCEP' title='Mid-Con Energy Partners'>MCEP</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BIOA' title='BioAmber'>OTC:BIOA</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TAHO' title='Tahoe Resources Inc.'>TAHO</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc'>PVG</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AGI' title='Alamos Gold Inc'>AGI</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3233964\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:30 pm\" data-tweet=\"$BCEI $WTI $MCEP - Energy/Materials - Top 5 Gainers / Losers as of 2:30 pm https://seekingalpha.com/news/3233964-energy-materials-top-5-gainers-losers-of-2-30-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3233964-energy-materials-top-5-gainers-losers-of-2-30-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233963\" data-ts=\"1483731171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233963-macquaries-5g-take-bullish-on-and-t-sprint-charter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macquarie&#39;s 5G take: Bullish on AT&amp;T, Sprint, Charter</a></h4><ul>   <li>Macquarie is staying bullish on AT&amp;T (<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='red'>-2.1%</font>), Sprint (<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a> <font color='red'>-0.5%</font>) and Charter (<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a> <font color='green'>+0.6%</font>) after hearing 5G strategies from the multitude of companies presenting at the Consumer Electronics Show.</li>    <li>Charter's confidence in its platform was the biggest surprise, Amy Yong and team write: \"With or without wireless owner economics, its standalone fiber-rich platform translates well in a 5G world. Charter has one of the largest fiber footprints and has committed to further expand it through all-fiber buildouts to 2M homes over the next five years.\"</li>    <li>That infrastructure will let them hit 10Gbps symmetrical speeds similar to 5G, Yong writes, and by 2018, wireless services will be offered using its MVNO agreement with Verizon. The firm boosted its price target to $317 (15.5 times estimated 2017 free cash flow/share), implying 6.4% upside.</li>    <li>Meanwhile, despite the end of promo pricing for DirecTV&nbsp;Now, AT&amp;T could add \"1M-plus subs in no time.\" Zero rating could reinvigorate wireless despite the less appealing price points. Macquarie boosted that price target to $48 (7.25 times estimated 2018 EBITDA), implying 16% upside.</li>    <li>As for Sprint, they stay Outperform-rated with a price target of $10.25, implying 17% upside. The company should see a stronger 5G position due to 204 MHz of spectrum and HPUE optimization technology, which should increase 2.5-GHz band coverage by 30% or more.</li>    <li>Amy Yong is <a href=\"https://www.tipranks.com/analysts/amy-yong\" target=\"_blank\">ranked No. 443</a> out of 4,369 analysts at TipRanks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233963\" data-linked=\"Macquarie&#39;s 5G take: Bullish on AT&amp;T, Sprint, Charter\" data-tweet=\"$T $T $S - Macquarie&#39;s 5G take: Bullish on AT&amp;T, Sprint, Charter https://seekingalpha.com/news/3233963-macquaries-5g-take-bullish-on-and-t-sprint-charter?source=tweet\" data-url=\"https://seekingalpha.com/news/3233963-macquaries-5g-take-bullish-on-and-t-sprint-charter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>232&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233959\" data-ts=\"1483730458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRAL\" target=\"_blank\">MRAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233959-tiny-consumer-lender-tenders-for-onemain-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tiny consumer lender tenders for OneMain Holdings</a></h4><ul><li>IEG Holdings (IEGH) is offering<a href=\"https://seekingalpha.com/filing/3348999\" target=\"_blank\"> two shares of its stock</a> for every one of OneMain Holdings (<a href='https://seekingalpha.com/symbol/OMF' title='OneMain Holdings, Inc.'>OMF</a> <font color='green'>+1.4%</font>).</li><li>IEG makes online, unsecured, consumer loans in the range of $2K-$10K, under the brand Mr. Amazing Loans.</li><li>IEGH is&nbsp;<font color='green'>up 36.7%</font>&nbsp;on the session to $7.45. At that price, two of its shares are worth $14.90 vs. the current price of $23.69 for OMF.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233959\" data-linked=\"Tiny consumer lender tenders for OneMain Holdings\" data-tweet=\"$MRAL $OMF - Tiny consumer lender tenders for OneMain Holdings https://seekingalpha.com/news/3233959-tiny-consumer-lender-tenders-for-onemain-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3233959-tiny-consumer-lender-tenders-for-onemain-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233954\" data-ts=\"1483727821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAYO\" target=\"_blank\">ZAYO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233954-moodys-rates-zayo-groups-acquisition-loans-for-electric-lightwave\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moody&#39;s rates Zayo Group&#39;s acquisition loans for Electric Lightwave</a></h4><ul>   <li>Moody's has given a Ba2 to a new $650M term loan at Zayo Holdings (<a href='https://seekingalpha.com/symbol/ZAYO' title='Zayo Group'>ZAYO</a> <font color='green'>+1.8%</font>), and a B3 to proposed $800M in senior unsecured notes used to prefund an acquisition of Electric Lightwave.</li>    <li>Zayo's acquisition plan for EL introduces <a href=\"https://www.moodys.com/research/Moodys-assigns-Ba2-to-Zayos-new-term-loan-and-B3--PR_360294?WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170106_PR_360294\" target=\"_blank\">higher execution risk</a> than prior deals, Moody's says, due to the acquired revenue mix and declining business segments.</li>    <li>\"Although Zayo's aggressive M&amp;A stance is generally credit negative, management's skill in navigating these transactions does offset a meaningful amount of this risk,\" the firm says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233954\" data-linked=\"Moody&#39;s rates Zayo Group&#39;s acquisition loans for Electric Lightwave\" data-tweet=\"$ZAYO - Moody&#39;s rates Zayo Group&#39;s acquisition loans for Electric Lightwave https://seekingalpha.com/news/3233954-moodys-rates-zayo-groups-acquisition-loans-for-electric-lightwave?source=tweet\" data-url=\"https://seekingalpha.com/news/3233954-moodys-rates-zayo-groups-acquisition-loans-for-electric-lightwave\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233950\" data-ts=\"1483725788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROP\" target=\"_blank\">ROP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233950-oppenheimer-co-upgrades-roper-technologies-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer &amp; Co. upgrades Roper Technologies to Outperform</a></h4><ul><li><a href=\"http://www.streetinsider.com/Analyst+Comments/Oppenheimer+Upgrades+Roper+Industries+%28ROP%29+to+Outperform/12401265.html\" target=\"_blank\">Analyst Christopher Glynn</a> moves from Perform on Roper Technologies (NYSE:<a href='https://seekingalpha.com/symbol/ROP' title='Roper Technologies, Inc.'>ROP</a>), citing expected 2017 free cash flow growth factoring in acquisition of Deltek and long-term outperformance due to cash compounding.</li><li>Establishes $225 target on shares,&nbsp;<font color='green'>higher by 1.98%</font>&nbsp;to $188.93 on today's session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233950\" data-linked=\"Oppenheimer &amp; Co. upgrades Roper Technologies to Outperform\" data-tweet=\"$ROP - Oppenheimer &amp; Co. upgrades Roper Technologies to Outperform https://seekingalpha.com/news/3233950-oppenheimer-co-upgrades-roper-technologies-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3233950-oppenheimer-co-upgrades-roper-technologies-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233948\" data-ts=\"1483725754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSY\" target=\"_blank\">HSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233948-credit-suisse-expects-eps-beat-from-hershey\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse expects EPS beat from Hershey</a></h4><ul><li>Hershey (<a href='https://seekingalpha.com/symbol/HSY' title='The Hershey Company'>HSY</a> <font color='green'>+1.2%</font>) rallies after Credit Suisse <a href=\"http://www.marketwatch.com/story/hershey-upgraded-on-expectation-it-will-exceed-earnings-expectations-after-years-of-misses-2017-01-06\" target=\"_blank\">upgrades</a> the food stock to Outperform from Neutral.</li><li>The firm expects Hershey to hit or exceed its EPS&nbsp;guidance when it reports Q4 results on January 26.</li><li>The price target on Hersey from CS goes to $117 from $106.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233948\" data-linked=\"Credit Suisse expects EPS beat from Hershey\" data-tweet=\"$HSY - Credit Suisse expects EPS beat from Hershey https://seekingalpha.com/news/3233948-credit-suisse-expects-eps-beat-from-hershey?source=tweet\" data-url=\"https://seekingalpha.com/news/3233948-credit-suisse-expects-eps-beat-from-hershey\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233946\" data-ts=\"1483725609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233946-financials-top-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/JTPY' title='JetPay Corporation'>JTPY</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/FAC' title='First Acceptance Corporation'>FAC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CART' title='Carolina Trust Bank'>CART</a> <font color='green'>+7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233946\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM\" data-tweet=\"$JTPY $FAC $CART - Financials - Top Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3233946-financials-top-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3233946-financials-top-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233945\" data-ts=\"1483724987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233945-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> ETRM <font color='green'>+125%</font>. <a href='https://seekingalpha.com/symbol/SSY' title='SunLink Health Systems, Inc'>SSY</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/ZFGN' title='Zafgen, Inc.'>ZFGN</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/QTNT' title='Quotient Limited'>QTNT</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/PTX' title='Pernix Therapeutics Holdings, Inc.'>PTX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/STML' title='Stemline Therapeutics'>STML</a> <font color='green'>+14%</font>. SKLN <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/COYN' title='COPsync, Inc.'>OTC:COYN</a> <font color='red'>-39%</font>. <a href='https://seekingalpha.com/symbol/RT' title='Ruby Tuesday, Inc.'>RT</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SMRT' title='Stein Mart, Inc.'>SMRT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CERC' title='Cerecor'>CERC</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/TAHO' title='Tahoe Resources Inc.'>TAHO</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/UEC' title='Uranium Energy Corp'>UEC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ICUI' title='ICU Medical, Inc.'>ICUI</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233945\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$RSLS $SSY $ZFGN - Midday Gainers / Losers https://seekingalpha.com/news/3233945-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3233945-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233943\" data-ts=\"1483724526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TERP\" target=\"_blank\">TERP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233943-terraform-power-to-sell-u-k-solar-portfolio-for-580m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TerraForm Power to sell U.K. solar portfolio for $580M</a></h4><ul>     <li>TerraForm Power (<a href='https://seekingalpha.com/symbol/TERP' title='TerraForm Power, Inc.'>TERP</a> <font color='green'>+2.1%</font>) is higher following news that it is <a href=\"https://seekingalpha.com/pr/16707357-terraform-power-announces-sale-uk-portfolio-optimize-fleet-position-company-future-growth\" target=\"_blank\">selling its U.K. portfolio</a> of 24 operating solar projects representing 365 MW to Vortex, a renewable energy platform managed by EFG Hermes&rsquo; P-E arm.</li><li>TERP says the deal is valued at $580M and represents  an implied multiple of ~16x its expected 2016  EBITDA contribution from the portfolio; TERP expects to receive ~$208M of  proceeds from the sale.</li><li>Upon  completion, TERP expects to reduce non-recourse project debt on  its balance sheet by $370M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233943\" data-linked=\"TerraForm Power to sell U.K. solar portfolio for $580M\" data-tweet=\"$TERP - TerraForm Power to sell U.K. solar portfolio for $580M https://seekingalpha.com/news/3233943-terraform-power-to-sell-u-k-solar-portfolio-for-580m?source=tweet\" data-url=\"https://seekingalpha.com/news/3233943-terraform-power-to-sell-u-k-solar-portfolio-for-580m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>176&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233942\" data-ts=\"1483723893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENT\" target=\"_blank\">ENT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233942-global-eagle-refinances-585m-in-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Eagle refinances $585M in debt</a></h4><ul>   <li>Global Eagle Entertainment (<a href='https://seekingalpha.com/symbol/ENT' title='Global Eagle Entertainment, Inc.'>ENT</a> <font color='red'>-1.7%</font>) has closed on more than a <a href=\"https://seekingalpha.com/pr/16707517-global-eagle-closes-new-500-million-term-loan-facility-new-85-million-revolving-credit\" target=\"_blank\">half-billion dollars in refinancing</a>.</li>    <li>The company refinanced existing facilities with a new $500M senior secured term loan, along with an $85M senior secured revolving credit facility.</li>    <li>The six-year $500M loan comes at Libor plus 600 basis points, and the $85M revolver (up from a previous $75.5M) comes at the same rate.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233942\" data-linked=\"Global Eagle refinances $585M in debt\" data-tweet=\"$ENT - Global Eagle refinances $585M in debt https://seekingalpha.com/news/3233942-global-eagle-refinances-585m-in-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3233942-global-eagle-refinances-585m-in-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233936\" data-ts=\"1483723522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTNT\" target=\"_blank\">QTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233936-quotients-mosiaq-shows-positive-results-in-antigen-typing-study-shares-ahead-21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quotient&#39;s MosiaQ shows positive results in antigen typing study; shares ahead 21%</a></h4><ul><li>Thinly traded micro cap Quotient (<a href='https://seekingalpha.com/symbol/QTNT' title='Quotient Limited'>QTNT</a> <font color='green'>+20.6%</font>) jumps on almost double normal volume in response to its <a href=\"https://seekingalpha.com/pr/16706933-quotient-limited-reports-positive-mosaiq-results-performance-evaluation-study-blood-grouping\" target=\"_blank\">announcement </a>of positive results from a performance evaluation antigen typing study using its automated&nbsp;<a href=\"http://www.quotientbd.com/mosaiq\" target=\"_blank\">MosiaQ </a>system, its platform for blood grouping and donor disease screening associated with transfusion diagnostics.</li><li>In a total of 804 samples, MosiaQ demonstrated sensitivity of 98.9% (9 false negatives) and specificity of 100% (0 false positives).</li><li>The company says that the European field trials should be completed in H1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233936\" data-linked=\"Quotient&#39;s MosiaQ shows positive results in antigen typing study; shares ahead 21%\" data-tweet=\"$QTNT - Quotient&#39;s MosiaQ shows positive results in antigen typing study; shares ahead 21% https://seekingalpha.com/news/3233936-quotients-mosiaq-shows-positive-results-in-antigen-typing-study-shares-ahead-21?source=tweet\" data-url=\"https://seekingalpha.com/news/3233936-quotients-mosiaq-shows-positive-results-in-antigen-typing-study-shares-ahead-21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233940\" data-ts=\"1483722889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZTCOY\" target=\"_blank\">ZTCOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233940-reuters-chinas-zte-to-cut-3000-jobs-sanctions-impending\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: China&#39;s ZTE to cut 3,000 jobs with sanctions impending</a></h4><ul>   <li>Telecom equipment maker ZTE (<a href='https://seekingalpha.com/symbol/ZTCOY' title='Zte Corp. ADR'>OTCPK:ZTCOY</a> <font color='red'>-3%</font>) is set to <a href=\"http://www.reuters.com/article/us-china-zte-idUSKBN14Q13Y\" target=\"_blank\">cut about 3,000 jobs</a> ahead of possible U.S. sanctions, Reuters reports.</li>    <li>The cuts would included some 600 jobs in its global handset operations, concentrated on a struggling unit in China, where a fifth of positions are set to be axed: \"Cuts in the handset business in China will be beyond 20 percent,\" a source told Reuters.</li>    <li>Another manager said that a list of names who had tried to apply to rival Huawei was circulated for likely cuts.</li>    <li>With a 10% market share (fourth-largest), ZTE is the only Chinese smartphone maker with a meaningful presence in the United States.</li>    <li>Sanctions (related to Iran sales) set to come into effect at the end of February could cripple ZTE's supply chain, with restrictions on component exports from Qualcomm, Microsoft and Intel.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233940\" data-linked=\"Reuters: China&#39;s ZTE to cut 3,000 jobs with sanctions impending\" data-tweet=\"$ZTCOY $ZTCOF - Reuters: China&#39;s ZTE to cut 3,000 jobs with sanctions impending https://seekingalpha.com/news/3233940-reuters-chinas-zte-to-cut-3000-jobs-sanctions-impending?source=tweet\" data-url=\"https://seekingalpha.com/news/3233940-reuters-chinas-zte-to-cut-3000-jobs-sanctions-impending\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233939\" data-ts=\"1483722878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGO\" target=\"_blank\">EGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233939-eldorado-gold-cuts-turkey-brazil-development-plans-on-lower-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eldorado Gold cuts Turkey, Brazil development plans on lower prices</a></h4><ul>     <li>Eldorado Gold (<a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='red'>-3.6%</font>) says it has indefinitely <a href=\"https://seekingalpha.com/pr/16707217-eldorado-announces-preliminary-2016-operational-results-2017-guidance\" target=\"_blank\">shelved expansion plans</a> for its Kisladag mine in Turkey and deferred a decision on developing a project in Brazil, citing lower gold prices.</li>     <li>EGO also lowers its planned 2017 capex to $425M, below its September forecast of $500M-$580M, primarily reflecting the suspension of Kisladag and the Tocantinzinho project in Brazil as well as changes in the spending schedule at the Skouries mine in Greece.</li>     <li>\"While the deferral of the Kisladag expansion and Tocantinzinho project reflect the company's focus on free cash flow under a lower gold price assumption, some investors may look at the lower production negatively depending on their gold price outlook,\" RBC Capital analyst Dan Rollins says.</li>     <li>EGO expects 2017 gold production of 365K-400K oz. and all-in sustaining cash costs of $845-$875/oz., which RBC says <a href=\"http://www.reuters.com/article/eldorado-gold-outlook-idUSL1N1EW0X1\" target=\"_blank\">matches its expectations</a>; the company cut the gold price it used in forecasting to $1,150/oz. from $1,300 in September.</li><li>EGO says 2016 all-in sustaining costs came in at ~$915/oz., below original 2016 guidance for $940-$980/oz.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233939\" data-linked=\"Eldorado Gold cuts Turkey, Brazil development plans on lower prices\" data-tweet=\"$EGO - Eldorado Gold cuts Turkey, Brazil development plans on lower prices https://seekingalpha.com/news/3233939-eldorado-gold-cuts-turkey-brazil-development-plans-on-lower-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3233939-eldorado-gold-cuts-turkey-brazil-development-plans-on-lower-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233935\" data-ts=\"1483722110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233935-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/HELE' title='Helen of Troy Limited'>HELE</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> XNY <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MERC' title='Mercer International Inc.'>MERC</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233935\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$FCAU $LFVN $HELE - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3233935-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3233935-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233933\" data-ts=\"1483721583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFY\" target=\"_blank\">INFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233933-clsa-downgrades-infosys-to-underperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CLSA downgrades Infosys to Underperform</a></h4><ul><li>A multi-grade move <a href=\"http://www.streetinsider.com/Downgrades/CLSA+Downgrades+Infosys+Technologies+%28INFY%29+to+Underperform/12402172.html\" target=\"_blank\">from Outperform prior</a>.</li><li>Infosys (NASDAQ:<a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited, Inc.'>INFY</a>)&nbsp;<font color='red'>-1.76%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233933\" data-linked=\"CLSA downgrades Infosys to Underperform\" data-tweet=\"$INFY - CLSA downgrades Infosys to Underperform https://seekingalpha.com/news/3233933-clsa-downgrades-infosys-to-underperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3233933-clsa-downgrades-infosys-to-underperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233930\" data-ts=\"1483720885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOV\" target=\"_blank\">DOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233930-dover-upgraded-to-buy-from-sell-ubs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dover upgraded to Buy from Sell at UBS</a></h4><ul><li>Dover (<a href='https://seekingalpha.com/symbol/DOV' title='Dover Corp'>DOV</a> <font color='green'>+2.3%</font>) enjoys strong gains after UBS <a href=\"http://www.streetinsider.com/Upgrades/UBS+Upgrades+Dover+Corp.+%28DOV%29+to+Buy/12401463.html\" target=\"_blank\">upgraded shares to Buy</a> from Sell with a $90 price target, raised from $65,  as the firm foresees a sharp recovery in 2017-18 driven by a rebound in U.S. rig  counts with strong incremental margins.</li><li>UBS notes operating profit in DOV's energy business is down 89% since 2014 and now represents 6% of segment profit vs. 34% in 2014, while revenues for the segment are down 45% and margins have  dropped to 5% from 23%; the segment bottomed at  break-even in Q2 2016 and began to improve sequentially in Q3.</li><li>UBS says its current estimates for DOV could prove conservative if the new Trump administration implements policies that encourage additional use of domestic oil.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233930\" data-linked=\"Dover upgraded to Buy from Sell at UBS\" data-tweet=\"$DOV - Dover upgraded to Buy from Sell at UBS https://seekingalpha.com/news/3233930-dover-upgraded-to-buy-from-sell-ubs?source=tweet\" data-url=\"https://seekingalpha.com/news/3233930-dover-upgraded-to-buy-from-sell-ubs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233923\" data-ts=\"1483719318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIVE\" target=\"_blank\">LIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233923-live-venturesminus-10-short-report-charges-paid-promotion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Live Ventures -10% as short report charges paid promotion</a></h4><ul>     <li>Live Ventures (NASDAQ:<a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a>) has taken a tumble on heavy volume, <font color='red'>down 10.5%</font>, after a short report terming it \"a stock promotion that has been aggressively pumped by some of the most notorious stock touts in the business.\"</li>     <li>The <a href=\"https://seekingalpha.com/article/4034769-live-ventures-exposed-massive-paid-promotions-heavy-accounting-manipulation-deficient-auditor\" target=\"_blank\">Mox Reports piece</a>, from SA contributor Richard Pearson, charges the company with taking a stock ride (from mid-November to Dec. 28, the stock rose 135%) on the back of paid promotions -- as much as $2M paid to hype the stock, the report says.</li>     <li>The company created \"earnings\" through multiple one-time accounting gains, the report says, and its auditor was cited for \"egregious and extensive audit deficiencies\" in 2016.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233923\" data-linked=\"Live Ventures -10% as short report charges paid promotion\" data-tweet=\"$LIVE - Live Ventures -10% as short report charges paid promotion https://seekingalpha.com/news/3233923-live-venturesminus-10-short-report-charges-paid-promotion?source=tweet\" data-url=\"https://seekingalpha.com/news/3233923-live-venturesminus-10-short-report-charges-paid-promotion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233898\" data-ts=\"1483718551\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233898-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> ETRM <font color='green'>+68%</font>. <a href='https://seekingalpha.com/symbol/SSY' title='SunLink Health Systems, Inc'>SSY</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/ZFGN' title='Zafgen, Inc.'>ZFGN</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/QTNT' title='Quotient Limited'>QTNT</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ICUI' title='ICU Medical, Inc.'>ICUI</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/GNVC' title='GenVec, Inc.'>GNVC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/OREX' title='Orexigen Therapeutics, Inc.'>OREX</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233898\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$RSLS $SSY $ZFGN - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3233898-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3233898-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233924\" data-ts=\"1483718292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233924-copsync-announces-1_15m-registered-direct-offering-shares-down-38\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">COPsync announces $1.15M registered direct offering; shares down 38%</a></h4><ul>     <li>COPsync (COYN&nbsp;<font color='red'>-38%</font>) has <a href=\"https://seekingalpha.com/pr/16707449-copsync-announces-1_15-million-registered-direct-offering\" target=\"_blank\">entered into securities purchase agreements</a> with certain accredited investors providing for the purchase and sale of 1.772M shares of common stock in a registered direct offering.</li>     <li>Concurrently, the company has agreed to sell class A and class B warrants to purchase up to 1.772M shares each with an exercise price of $1.03/share and will be exercisable beginning six months following the closing date of the private placement. The combined purchase price for one registered share of common stock, one unregistered class A warrant and one unregistered class B warrant is $0.65.</li>     <li>The class A and B warrants will expire on the 18 month and 5 years, respectively, from the date on which they become exercisable.</li><li>The Company intends to use the aggregate net proceeds for expansion of sales and marketing, working capital, continued product development and network enhancement, and other corporate purposes.</li>           </ul><div class=\"tiny-share-widget\" data-id=\"3233924\" data-linked=\"COPsync announces $1.15M registered direct offering; shares down 38%\" data-tweet=\"COPsync announces $1.15M registered direct offering; shares down 38% https://seekingalpha.com/news/3233924-copsync-announces-1_15m-registered-direct-offering-shares-down-38?source=tweet\" data-url=\"https://seekingalpha.com/news/3233924-copsync-announces-1_15m-registered-direct-offering-shares-down-38\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233918\" data-ts=\"1483717616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233918-t-looks-to-avoid-fcc-review-in-time-warner-buyout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T looks to avoid FCC review in Time Warner buyout</a></h4><ul>   <li>AT&amp;T (<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='red'>-2%</font>) thinks it sees an <a href=\"https://www.bloomberg.com/news/articles/2017-01-06/at-t-sees-avoiding-fcc-review-by-not-taking-time-warner-licenses\" target=\"_blank\">easier path</a> to wrapping its $85B purchase of Time Warner (<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a> <font color='green'>+0.4%</font>) -- one that excludes what could be a problematic review at the FCC.</li>    <li>The prospect of Time Warner needing to transfer FCC licenses raised the specter of a full review by the communications agency.</li><li>But the companies now say: &ldquo;While subject to change, it is currently anticipated that Time Warner will not need to transfer any of its FCC licenses to AT&amp;T in order to continue to conduct its business operations after the closing of the transaction.\"</li>    <li>The FCC conducts broader reviews than the Justice Department, looking not only at competitive concerns but also whether deals are in the public interest.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233918\" data-linked=\"AT&amp;T looks to avoid FCC review in Time Warner buyout\" data-tweet=\"$T $T $TWX - AT&amp;T looks to avoid FCC review in Time Warner buyout https://seekingalpha.com/news/3233918-t-looks-to-avoid-fcc-review-in-time-warner-buyout?source=tweet\" data-url=\"https://seekingalpha.com/news/3233918-t-looks-to-avoid-fcc-review-in-time-warner-buyout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233916\" data-ts=\"1483717505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDLZ\" target=\"_blank\">MDLZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233916-mondelez-and-kraft-heinz-back-in-rumor-mill\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mondelez and Kraft Heinz back in the rumor mill</a></h4><ul> <li>Mondelez International (<a href='https://seekingalpha.com/symbol/MDLZ' title='Mondelēz International, Inc.'>MDLZ</a> <font color='green'>+0.4%</font>) and Kraft Heinz (<a href='https://seekingalpha.com/symbol/KHC' title='The Kraft Heinz Company'>KHC</a> <font color='red'>-0.2%</font>) have both moved higher from their prior levels as more speculation on a mega-food merger make the rounds.</li> <li>Mondelez is only about a buck away from its 52-week high. At least some M&amp;A premium is already baked in.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3233916\" data-linked=\"Mondelez and Kraft Heinz back in the rumor mill\" data-tweet=\"$MDLZ $MDLZ $KHC - Mondelez and Kraft Heinz back in the rumor mill https://seekingalpha.com/news/3233916-mondelez-and-kraft-heinz-back-in-rumor-mill?source=tweet\" data-url=\"https://seekingalpha.com/news/3233916-mondelez-and-kraft-heinz-back-in-rumor-mill\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233914\" data-ts=\"1483717289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233914-bristol-myers-suspends-recruitment-in-mid-stage-opdivo-study-in-advanced-sarcoma-shares-ease\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristol-Myers suspends recruitment in mid-stage Opdivo study in advanced sarcoma; shares ease 1%</a></h4><ul><li>Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='red'>-0.8%</font>) is under pressure in early trading after enrollment was suspended in a National Cancer Institute-sponsored <a href=\"https://clinicaltrials.gov/ct2/show/NCT02500797?recr=Suspended&amp;lup_s=01%2F01%2F2017&amp;rank=5\" target=\"_blank\">Phase 2 clinical trial</a> assessing Opdivo (nivolumab) alone and with Yervoy (ipilimumab) in patients with metastatic or unresectable sarcoma (soft tissue cancer).</li><li>The aim of the study is to determine if the combination of the two drugs works better than Opdivo as monotherapy.</li><li>The primary endpoint is confirmed response rate. According to ClinicalTrials.gov, the study commenced in July 2015 and is projected to be completed in November 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233914\" data-linked=\"Bristol-Myers suspends recruitment in mid-stage Opdivo study in advanced sarcoma; shares ease 1%\" data-tweet=\"$BMY - Bristol-Myers suspends recruitment in mid-stage Opdivo study in advanced sarcoma; shares ease 1% https://seekingalpha.com/news/3233914-bristol-myers-suspends-recruitment-in-mid-stage-opdivo-study-in-advanced-sarcoma-shares-ease?source=tweet\" data-url=\"https://seekingalpha.com/news/3233914-bristol-myers-suspends-recruitment-in-mid-stage-opdivo-study-in-advanced-sarcoma-shares-ease\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233913\" data-ts=\"1483716924\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHAK\" target=\"_blank\">SHAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233913-shake-shack-tracks-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shake Shack tracks lower</a></h4><ul> <li>Shake Shack (NYSE:<a href='https://seekingalpha.com/symbol/SHAK' title='Shake Shack'>SHAK</a>) is <font color='red'>down 6%</font> after Buckingham Research lowers its rating to Neutral from Buy.</li> <li>The investment firm is concerned over the \"near-flawless\" execution it will take to hit valuation expectations.</li> <li>Shake Shack delivered an \"incomplete\" message on sales as part of its management roster <a href=\"https://seekingalpha.com/news/3233757-shake-shack-brings-coo-cfo-exit\" target=\"_blank\">change </a>announced last night, notes BR.</li> <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233913\" data-linked=\"Shake Shack tracks lower\" data-tweet=\"$SHAK - Shake Shack tracks lower https://seekingalpha.com/news/3233913-shake-shack-tracks-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3233913-shake-shack-tracks-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233910\" data-ts=\"1483716386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSY\" target=\"_blank\">SSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233910-sunlink-up-32-on-plan-to-repurchase-3m-shares-1_50\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunLink up 32% on plan to repurchase 3M shares at $1.50</a></h4><ul><li>Thinly traded nano cap SunLink Health Systems (<a href='https://seekingalpha.com/symbol/SSY' title='SunLink Health Systems, Inc'>SSY</a> <font color='green'>+32.1%</font>) heads north on a 4x surge in volume, albeit on turnover of only 180K shares, in response to its <a href=\"https://seekingalpha.com/pr/16707044-sunlink-health-systems-inc-announces-intention-commence-tender-offer-repurchase-3000-000\" target=\"_blank\">announcement </a>that it plans to repurchase up to 3M common shares at $1.50. The buyback, representing almost 32% of the company's outstanding stock, will be partially funded with cash on hand.</li><li>Yesterday's close was $1.12.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233910\" data-linked=\"SunLink up 32% on plan to repurchase 3M shares at $1.50\" data-tweet=\"$SSY - SunLink up 32% on plan to repurchase 3M shares at $1.50 https://seekingalpha.com/news/3233910-sunlink-up-32-on-plan-to-repurchase-3m-shares-1_50?source=tweet\" data-url=\"https://seekingalpha.com/news/3233910-sunlink-up-32-on-plan-to-repurchase-3m-shares-1_50\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233906\" data-ts=\"1483715101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIMO\" target=\"_blank\">SIMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233906-silicon-motion-notes-preliminary-q4-results-upper-range-of-projections\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Silicon Motion notes preliminary Q4 results at upper range of projections</a></h4><ul><li>Sequential revenue decline <a href=\"https://seekingalpha.com/pr/16707297-silicon-motion-announces-preliminary-fourth-quarter-2016-revenue-earnings-conference-call\" target=\"_blank\">is anticipated</a> near the 9% level of initial 9%-14% guidance range, with gross margin projected in upper portion of initial 48.5%-50.5% range.</li><li>Finalized Q4 posting is due January 23.</li><li>Silicon Motion (NASDAQ:<a href='https://seekingalpha.com/symbol/SIMO' title='Silicon Motion Technology Corporation'>SIMO</a>)&nbsp;<font color='green'>+2.7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233906\" data-linked=\"Silicon Motion notes preliminary Q4 results at upper range of projections\" data-tweet=\"$SIMO - Silicon Motion notes preliminary Q4 results at upper range of projections https://seekingalpha.com/news/3233906-silicon-motion-notes-preliminary-q4-results-upper-range-of-projections?source=tweet\" data-url=\"https://seekingalpha.com/news/3233906-silicon-motion-notes-preliminary-q4-results-upper-range-of-projections\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233901\" data-ts=\"1483715061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYNO\" target=\"_blank\">CYNO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233901-northcoasts-abrupt-reversal-of-opinion-on-cynosure-pressures-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northcoast&#39;s abrupt reversal of opinion on Cynosure pressures shares</a></h4><ul><li>Aesthetic laser maker Cynosure (<a href='https://seekingalpha.com/symbol/CYNO' title='Cynosure, Inc.'>CYNO</a> <font color='red'>-4.7%</font>) is down out of the gates this morning, albeit on average volume, on the heels of a Sell recommendation from independent research shop <a href=\"http://www.northcoastresearch.com/\" target=\"_blank\">Northcoast Research</a>. In mid-November, Northcoast rated the stock a Buy.</li><li>In Q3, the company posted a 36% gain in revenue and 38% jump in non-GAAP EPS. Consensus view for Q4 is non-GAAP EPS of $0.41 (+32%) on revenues of $120M (+17%).</li><li>Shares had rallied ~17% over the past several weeks until today.</li><li><strong>Update</strong>: The company will <a href=\"https://seekingalpha.com/pr/16707598-cynosure-host-fourth-quarter-2016-financial-results-conference-call-february-7\" target=\"_blank\">release </a>Q4 results before the open on February 7.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233901\" data-linked=\"Northcoast&#39;s abrupt reversal of opinion on Cynosure pressures shares\" data-tweet=\"$CYNO - Northcoast&#39;s abrupt reversal of opinion on Cynosure pressures shares https://seekingalpha.com/news/3233901-northcoasts-abrupt-reversal-of-opinion-on-cynosure-pressures-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3233901-northcoasts-abrupt-reversal-of-opinion-on-cynosure-pressures-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233896\" data-ts=\"1483714114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYNO\" target=\"_blank\">CYNO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233896-cynosureminus-4-on-downgrade-to-sell-northcoast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cynosure -4% on downgrade to Sell at Northcoast</a></h4><ul><li>Checks read terrible, says Northcoast Research, downgrading Cynosure (<a href='https://seekingalpha.com/symbol/CYNO' title='Cynosure, Inc.'>CYNO</a> <font color='red'>-4.3%</font>) to Sell with $40 price target (<font color='red'>20% downside</font>&nbsp;from yesterday's close).</li><li><a href=\"https://twitter.com/thenotablecalls/status/817377995073736705\" target=\"_blank\">via Notable Calls</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3233896\" data-linked=\"Cynosure -4% on downgrade to Sell at Northcoast\" data-tweet=\"$CYNO - Cynosure -4% on downgrade to Sell at Northcoast https://seekingalpha.com/news/3233896-cynosureminus-4-on-downgrade-to-sell-northcoast?source=tweet\" data-url=\"https://seekingalpha.com/news/3233896-cynosureminus-4-on-downgrade-to-sell-northcoast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233894\" data-ts=\"1483713239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GG\" target=\"_blank\">GG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233894-gold-miners-open-lower-yellow-metal-retreats-following-jobs-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold miners open lower as yellow metal retreats following jobs report</a></h4><ul><li>The <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a> is&nbsp;<font color='green'>up 20%</font>&nbsp;in the past five sessions, but is<font color='red'> lower by 2.25%</font>&nbsp;in early action today as this morning's roughly inline jobs report puts to rest any idea the Fed is about to get less hawkish.</li><li>Gold, the metal, is&nbsp;<font color='red'>down 0.5%</font>&nbsp;to $1,175 per ounce.</li><li>Goldcorp (<a href='https://seekingalpha.com/symbol/GG' title='Goldcorp Inc.'>GG</a> <font color='red'>-0.5%</font>), Barrick Gold (ABX <font color='red'>-1.2%</font>), Kincross Gold (<a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color='red'>-1.4%</font>), Newmont Mining (<a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation &#40;Holding Company&#41;'>NEM</a> <font color='red'>-1%</font>), Gold Fields (<a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='red'>-1.3%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233873-roughly-inline-employment-report-likely-keep-fed-course\" target=\"_blank\">Roughly inline employment report likely to keep Fed on course</a> (Jan. 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233878-dollar-resumes-upward-path-jobs-numbers-gold-resumes-lower\" target=\"_blank\">Dollar resumes upward path after jobs numbers; gold resumes lower</a> (Jan. 6)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/JNUG' title='Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF'>JNUG</a>, GLDX, <a href='https://seekingalpha.com/symbol/JDST' title='Direxion Daily Junior Gold Miners Index Bear 3x Shares ETF'>JDST</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/PSAU' title='Invesco Global Gold and Precious Metals Portfolio ETF'>PSAU</a>, <a href='https://seekingalpha.com/symbol/SGDJ' title='Sprott Junior Gold Miners ETF'>SGDJ</a>, <a href='https://seekingalpha.com/symbol/TGLDX' title='Tocqueville Gold Fund No Load'>TGLDX</a>, <a href='https://seekingalpha.com/symbol/GDJJ' title='ProShares Ultra Junior Miners ETF'>GDJJ</a>, <a href='https://seekingalpha.com/symbol/GDXX' title='ProShares Ultra Gold Miners ETF'>GDXX</a>, <a href='https://seekingalpha.com/symbol/GDXS' title='ProShares UltraShort Gold Miners ETF'>GDXS</a>, <a href='https://seekingalpha.com/symbol/MELT' title='Direxion Daily Gold Miners Index Bear 1x Shares ETF'>MELT</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3233894\" data-linked=\"Gold miners open lower as yellow metal retreats following jobs report\" data-tweet=\"$GG $GDX $GG - Gold miners open lower as yellow metal retreats following jobs report https://seekingalpha.com/news/3233894-gold-miners-open-lower-yellow-metal-retreats-following-jobs-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3233894-gold-miners-open-lower-yellow-metal-retreats-following-jobs-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233884\" data-ts=\"1483712739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OREX\" target=\"_blank\">OREX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233884-investors-unmoved-over-data-from-real-world-contrave-study-published-in-obesity-journal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors unmoved over data from real-world Contrave study published in Obesity journal; Orexigen off 2% premarket</a></h4><ul><li>Orexigen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OREX' title='Orexigen Therapeutics, Inc.'>OREX</a>) eases&nbsp;<font color='red'>2%</font>&nbsp;premarket on increased volume. Investors appear a bit apathetic after the <a href=\"https://seekingalpha.com/pr/16707327-orexigen-therapeutics-announces-publication-contrave-naltrexone-hcl-bupropion-hcl-extended\" target=\"_blank\">results </a>from the company's open-label real-world study, IGNITE, were published in <em>Obesity</em>, the peer-reviewed journal of The Obesity Society.</li><li>IGNITE was designed to assess the use of obesity drug Contrave in combination with a commercially available lifestyle intervention program compared to usual care in a real-world weight-loss setting in 242 obese or overweight adults aged 18 to 60 with dyslipidemia and/or controlled hypertension.</li><li>The results were consistent with the company's four previous Phase 3 studies. Participants receiving Contrave experienced weight loss of 9.5% compared to 0.9% for usual care (p&lt;0.0001).</li><li>Longs shouldn't necessarily be worried. Shares had more than doubled over past several days ahead of the news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233884\" data-linked=\"Investors unmoved over data from real-world Contrave study published in Obesity journal; Orexigen off 2% premarket\" data-tweet=\"$OREX - Investors unmoved over data from real-world Contrave study published in Obesity journal; Orexigen off 2% premarket https://seekingalpha.com/news/3233884-investors-unmoved-over-data-from-real-world-contrave-study-published-in-obesity-journal?source=tweet\" data-url=\"https://seekingalpha.com/news/3233884-investors-unmoved-over-data-from-real-world-contrave-study-published-in-obesity-journal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233892\" data-ts=\"1483712480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233892-premarket-gainers-losers-of-9-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:15 am</a></h4><ul> <li><b>Gainers:</b> ETRM <font color='green'>+69%</font>. <a href='https://seekingalpha.com/symbol/STML' title='Stemline Therapeutics'>STML</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/MDCO' title='The Medicines Company'>MDCO</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='green'>+6%</font>. URRE <font color='green'>+4%</font>. <a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RT' title='Ruby Tuesday, Inc.'>RT</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ICUI' title='ICU Medical, Inc.'>ICUI</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3233892\" data-linked=\"Premarket Gainers / Losers as of 9:15 am\" data-tweet=\"$RSLS $STML $GSAT - Premarket Gainers / Losers as of 9:15 am https://seekingalpha.com/news/3233892-premarket-gainers-losers-of-9-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3233892-premarket-gainers-losers-of-9-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233890\" data-ts=\"1483712464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSAT\" target=\"_blank\">GSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233890-globalstar-up-10_8-discusses-fcc-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globalstar up 10.8% as it discusses FCC approval</a></h4><ul>   <li>Globalstar (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a>), in the middle of a conference call discussing the FCC's order allowing for its Terrestrial Low-Power Service, is <font color='green'>up 10.8%</font> premarket.</li>    <li>The move's a bit of relief as well after the stock sold off 8.2% yesterday.</li>    <li>The stock's <font color='green'>up 9%</font> over the past 12 months, but has more than doubled since Dec. 1.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233890\" data-linked=\"Globalstar up 10.8% as it discusses FCC approval\" data-tweet=\"$GSAT - Globalstar up 10.8% as it discusses FCC approval https://seekingalpha.com/news/3233890-globalstar-up-10_8-discusses-fcc-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/3233890-globalstar-up-10_8-discusses-fcc-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233886\" data-ts=\"1483712115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCAU\" target=\"_blank\">FCAU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233886-fiat-chrysler-soars-to-52-week-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fiat Chrysler soars to 52-week high</a></h4><ul> <li>Fiat Chrysler Automobiles (NYSE:<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a>) trades higher after management struck a confident tone in Europe earlier today on the company hitting 2018 targets.</li> <li>The stock was also added to the Goldman Sachs Pan-Europe Conviction Buy List.</li><li>Source: Bloomberg</li> <li>FCAU <font color='green'>+4.59%</font> premarket to $10.26 vs. a 52-week trading range of $5.45 to $9.91.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3233886\" data-linked=\"Fiat Chrysler soars to 52-week high\" data-tweet=\"$FCAU - Fiat Chrysler soars to 52-week high https://seekingalpha.com/news/3233886-fiat-chrysler-soars-to-52-week-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3233886-fiat-chrysler-soars-to-52-week-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233882\" data-ts=\"1483711409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RT\" target=\"_blank\">RT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233882-ruby-tuesday-looks-for-fresh-start-after-rough-fq2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ruby Tuesday looks for &#39;fresh&#39; start after rough FQ2</a></h4><ul> <li>Ruby Tuesday (NYSE:<a href='https://seekingalpha.com/symbol/RT' title='Ruby Tuesday, Inc.'>RT</a>) is sharply lower after the company missed FQ2 estimates by a wide margin.</li> <li>Same-restaurant sales were down 3.1% during the period.</li> <li>Management has a plan looking forward that involves new initiatives. A hint on the direction is that the company used the word \"fresh\" 24 times in its press <a href=\"https://seekingalpha.com/pr/16706964-ruby-tuesday-inc-reports-fiscal-second-quarter-2017-financial-results\" target=\"_blank\">release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233763-ruby-tuesday-reports-fq2-results\" target=\"_blank\">Ruby Tuesday reports FQ2 results</a> (Jan. 5)</li> <li>RT <font color='red'>-13.60%</font> premarket to $3.05.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233882\" data-linked=\"Ruby Tuesday looks for &#39;fresh&#39; start after rough FQ2\" data-tweet=\"$RT - Ruby Tuesday looks for &#39;fresh&#39; start after rough FQ2 https://seekingalpha.com/news/3233882-ruby-tuesday-looks-for-fresh-start-after-rough-fq2?source=tweet\" data-url=\"https://seekingalpha.com/news/3233882-ruby-tuesday-looks-for-fresh-start-after-rough-fq2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233880\" data-ts=\"1483711233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBIX\" target=\"_blank\">NBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233880-new-operating-chief-neurocrine-shares-up-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New operating chief at Neurocrine; shares up 5% premarket</a></h4><ul><li>Neurocrine Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a>) <a href=\"https://seekingalpha.com/pr/16707344-neurocrine-biosciences-announces-appointment-david-alexandre-gros-m-d-president-chief\" target=\"_blank\">appoints </a>David-Alexander Gros, M.D., as President and Chief Operating Officer. He joins the firm from Alnylam Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a>) where he was SVP, Chief Business Officer.</li><li>Shares are up&nbsp;<font color='green'>5%</font>&nbsp;premarket on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233880\" data-linked=\"New operating chief at Neurocrine; shares up 5% premarket\" data-tweet=\"$NBIX $NBIX $ALNY - New operating chief at Neurocrine; shares up 5% premarket https://seekingalpha.com/news/3233880-new-operating-chief-neurocrine-shares-up-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3233880-new-operating-chief-neurocrine-shares-up-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233879\" data-ts=\"1483711169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233879-gopro-downgraded-to-underperform-longbow-research\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoPro downgraded to Underperform at Longbow Research</a></h4><ul><li>Anticipating Q4 camera sales to come in below expectations, attributed to a number of observations inclusive of negative consumer searches in December, internal funding of late-Q4 discounts through issuance of gift cards at various sales channels and continuing inventory overhang of discounted HERO, HERO+ and LCD products, analyst Joe&nbsp;Wittine moves negative for a time period&nbsp;\"inherently short-term in nature\" as M&amp;A potential is considered not to be ruled out.</li><li>Sets target on GoPro (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a>), trading&nbsp;<font color='red'>lower by 2.57%</font>&nbsp;pre-market to $9.11, at $7.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233879\" data-linked=\"GoPro downgraded to Underperform at Longbow Research\" data-tweet=\"$GPRO - GoPro downgraded to Underperform at Longbow Research https://seekingalpha.com/news/3233879-gopro-downgraded-to-underperform-longbow-research?source=tweet\" data-url=\"https://seekingalpha.com/news/3233879-gopro-downgraded-to-underperform-longbow-research\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233878\" data-ts=\"1483711112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233878-dollar-resumes-upward-path-after-jobs-numbers-gold-resumes-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar resumes upward path after jobs numbers; gold resumes lower</a></h4><ul><li>King dollar had stumbled out of the block this year, but it's headed higher as this <a href=\"https://seekingalpha.com/news/3233865-slight-miss-december-jobs-ue-rate-edges-higher\" target=\"_blank\">morning's roughly inline</a> employment report allayed any growth worries or idea the Fed might cool its hawkish attitude.</li><li>The headline jobs number of 156K was slightly below expectations, but prior months' gains were revised higher.</li><li><a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a> is<font color='green'> up 0.5%</font>&nbsp;premarket, with the euro (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a>), pound (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXB' title='CurrencyShares British Pound Sterling Trust ETF'>FXB</a>), yen (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXY' title='CurrencyShares Japanese Yen Trust ETF'>FXY</a>), Swiss franc (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXF' title='CurrencyShares Swiss Franc Trust ETF'>FXF</a>), and aussie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXA' title='CurrencyShares Australian Dollar Trust ETF'>FXA</a>) all lower vs. the greenback.</li><li>Gold had managed to put together a rally over the past few sessions, but it's moved lower since the number, now&nbsp;<font color='red'>down 0.7%</font>&nbsp;to $1,173 per ounce. <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>&nbsp;<font color='red'>-0.7%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3233878\" data-linked=\"Dollar resumes upward path after jobs numbers; gold resumes lower\" data-tweet=\"$UUP $FXE $FXB - Dollar resumes upward path after jobs numbers; gold resumes lower https://seekingalpha.com/news/3233878-dollar-resumes-upward-path-after-jobs-numbers-gold-resumes-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3233878-dollar-resumes-upward-path-after-jobs-numbers-gold-resumes-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233873\" data-ts=\"1483710434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233873-roughly-inline-employment-report-likely-to-keep-fed-on-course\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roughly inline employment report likely to keep Fed on course</a></h4><ul><li>While the headline jobs gain of 156K missed expectations for 178K, November's originally-reported 178K advance was revised up to 204K. October was revised down to 135K from 142K. Taken together, previous months' revisions were up 19K.</li><li>The average workweek was flat at 34.3 hours.</li><li>Average hourly earnings gained $0.10 to $26 for a 2.9% Y/Y advance.</li><li>The labor force participation rate edged higher to 62.7% - flat from one year ago.</li><li>The broader U-6 unemployment rate dipped to 9.2%. One year ago, it was 9.9%.</li><li>Bond bears had greatly eased bets in the days ahead of the report, but they're back to pressing as the print will do nothing to dissuade economy bulls (or the Fed from its tightening course). The 10-year Treasury yield is up 3.4 bps to 2.383%.</li><li><a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='red'>-0.4%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='green'>+0.8%</font>&nbsp;premarket</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233865-slight-miss-december-jobs-ue-rate-edges-higher\" target=\"_blank\">Slight miss for December jobs; UE rate edges higher</a> (Jan. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3233873\" data-linked=\"Roughly inline employment report likely to keep Fed on course\" data-tweet=\"$TLT $TBT - Roughly inline employment report likely to keep Fed on course https://seekingalpha.com/news/3233873-roughly-inline-employment-report-likely-to-keep-fed-on-course?source=tweet\" data-url=\"https://seekingalpha.com/news/3233873-roughly-inline-employment-report-likely-to-keep-fed-on-course\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233869\" data-ts=\"1483710170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANW\" target=\"_blank\">ANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233869-aegean-marine-to-launch-new-market-in-germany\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegean Marine to launch new market in Germany</a></h4><ul>     <li>Aegean Marine Petroleum Network (<a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a>) <font color='green'>+3.3%</font> premarket after announcing the launch of a <a href=\"https://seekingalpha.com/pr/16706985-aegean-marine-petroleum-network-inc-announces-launch-new-market-rostock-germany\" target=\"_blank\">new service center in Rostock, Germany,</a> that will serve all German Baltic Sea ports and southern Scandinavian ports.</li>     <li>Operations will be managed by OBAST  Bunkering &amp; Trading, a physical bunker supplier and  cargo oil trader; under the deal terms, ANW will acquire OBAST's existing share capital.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233869\" data-linked=\"Aegean Marine to launch new market in Germany\" data-tweet=\"$ANW - Aegean Marine to launch new market in Germany https://seekingalpha.com/news/3233869-aegean-marine-to-launch-new-market-in-germany?source=tweet\" data-url=\"https://seekingalpha.com/news/3233869-aegean-marine-to-launch-new-market-in-germany\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233867\" data-ts=\"1483709595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALL\" target=\"_blank\">CALL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233867-magicjack-to-review-activists-slate-after-yesterdays-11-advance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MagicJack to review activist&#39;s slate after yesterday&#39;s 11% advance</a></h4><ul><li>Carnegie Technologies (an owner of 1.6% of the company) yesterday <a href=\"https://seekingalpha.com/pr/16706494-correcting-replacing-carnegie-technologies-founder-paul-posner-nominate-five-highly-qualified\" target=\"_blank\">announced its intention</a> to try and purchase magicJack (NASDAQ:<a href='https://seekingalpha.com/symbol/CALL' title='magicJack VocalTec Communications Ltd.'>CALL</a>) for $8.50 per share, and nominated five to the company board.</li><li>The stock&nbsp;<font color='green'>gained 10.95%</font>&nbsp;to close at $8.10.</li><li>MagicJack <a href=\"https://seekingalpha.com/pr/16707313-magicjack-review-carnegie-s-director-nominees\" target=\"_blank\">this morning says</a> it will review the nominations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233867\" data-linked=\"MagicJack to review activist&#39;s slate after yesterday&#39;s 11% advance\" data-tweet=\"$CALL - MagicJack to review activist&#39;s slate after yesterday&#39;s 11% advance https://seekingalpha.com/news/3233867-magicjack-to-review-activists-slate-after-yesterdays-11-advance?source=tweet\" data-url=\"https://seekingalpha.com/news/3233867-magicjack-to-review-activists-slate-after-yesterdays-11-advance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233856\" data-ts=\"1483708436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233856-beast-mode-balance-sheet-noted-rbc-upgrades-disney\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&quot;Beast mode balance sheet&quot; noted as RBC upgrades Disney</a></h4><ul><li>Investor sentiment has turned on Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>), says Steven Cahall, with fears subsiding over distribution revenue and ESPN (a near-20% run higher since early Nov. would seem to indicate so).</li><li>Then there's \"massive balance sheet potential\": Disney is levered at just 1x EBITDA; at 4.5x, the company would have more than $65B in firepower for transformative M&amp;A.</li><li>He upgrades to Outperform with $130 price target (<font color='green'>more than 20% upside</font>).</li><li>Shares&nbsp;<font color='green'>+0.8%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3233856\" data-linked=\"&quot;Beast mode balance sheet&quot; noted as RBC upgrades Disney\" data-tweet=\"$DIS - &quot;Beast mode balance sheet&quot; noted as RBC upgrades Disney https://seekingalpha.com/news/3233856-beast-mode-balance-sheet-noted-rbc-upgrades-disney?source=tweet\" data-url=\"https://seekingalpha.com/news/3233856-beast-mode-balance-sheet-noted-rbc-upgrades-disney\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233855\" data-ts=\"1483708091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRTX\" target=\"_blank\">MRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233855-mirati-prices-equity-offering-shares-ease-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mirati prices equity offering; shares ease 3% premarket</a></h4><ul><li>Mirati Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRTX' title='Mirati Therapeutics, Inc.'>MRTX</a>) <a href=\"https://seekingalpha.com/pr/16707260-mirati-therapeutics-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 4,350,176 shares of common stock at $5.60. In addition, the company is offering funds affiliated with Boxer Capital, LLC pre-funded warrants to purchase up to 7,258,263 common shares at $5.599 per warrant. Gross proceeds should be ~$65M.</li><li>Underwriters over-allotment is an additional 652,526 common shares. Closing date is January 11.</li><li>Net proceeds will be used for general corporate purposes.</li><li>Shares are down&nbsp;<font color='red'>3%</font>&nbsp;premarket but only on turnover of 600. Yesterday's close was $5.90.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233855\" data-linked=\"Mirati prices equity offering; shares ease 3% premarket\" data-tweet=\"$MRTX - Mirati prices equity offering; shares ease 3% premarket https://seekingalpha.com/news/3233855-mirati-prices-equity-offering-shares-ease-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3233855-mirati-prices-equity-offering-shares-ease-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233846\" data-ts=\"1483707437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233846-teva-sees-2017-eps-of-4_90-5_30-versus-consensus-of-5_44-shares-ease-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva sees 2017 EPS of $4.90 - 5.30 versus consensus of $5.44; shares ease 2% premarket</a></h4><ul><li>Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) <a href=\"https://seekingalpha.com/pr/16707247-teva-provides-2017-financial-outlook\" target=\"_blank\">releases </a>its 2017 guidance.</li><li>Revenues: $23.8B - 24.5B (consensus: $24.8B); EPS: $4.90 - 5.30 (consensus: $5.44); cash flow ops ($5.7B - 6.1B) (+14 - 27% yoy).</li><li>Generics: revenues: $13.9B - 14.3B; segment profit: $4.1B - 4.3B.</li><li>Specialty (ex-Multiple Sclerosis): revenues: $4.0B - 4.2B; segment profit: $1.1B - 1.3B.</li><li>Multiple Sclerosis: revenues: $3.8B - 3.9B; segment profit: $3.05B - 3.10B.</li><li>Key product sales: Copaxone: $3.8B - 3.9B; Bendeka &amp; Treanda: $600M - 660M; ProAir: $440M - 540M; Qvar: $450M - 490M; Azilect: $110M - 190M.</li><li>Shares are down&nbsp;<font color='red'>2%</font>&nbsp;premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233846\" data-linked=\"Teva sees 2017 EPS of $4.90 - 5.30 versus consensus of $5.44; shares ease 2% premarket\" data-tweet=\"$TEVA - Teva sees 2017 EPS of $4.90 - 5.30 versus consensus of $5.44; shares ease 2% premarket https://seekingalpha.com/news/3233846-teva-sees-2017-eps-of-4_90-5_30-versus-consensus-of-5_44-shares-ease-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3233846-teva-sees-2017-eps-of-4_90-5_30-versus-consensus-of-5_44-shares-ease-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233840\" data-ts=\"1483706368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDCO\" target=\"_blank\">MDCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233840-jefferies-raises-fair-value-target-for-medicines-company-to-49-on-amgen-repatha-patent-win\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies raises fair value target for The Medicines Company to $49 on Amgen Repatha patent win; shares ahead 8% premarket</a></h4><ul><li>The Medicines Company (NASDAQ:<a href='https://seekingalpha.com/symbol/MDCO' title='The Medicines Company'>MDCO</a>) is up&nbsp;<font color='green'>8%</font>&nbsp;premarket, albeit on only 1,000 shares, on the heels of Amgen's (NASDAQ:<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>) PCSK9-inhibitor patent victory over Regeneron Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a>) and Sanofi (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>). The permanent injunction, if upheld, will eliminate a competitor [Praluent (alirocumab)] for MDCO's high cholesterol candidate inclisiran, currently in Phase 3 development.</li><li>Inclisiran (PCSK9si)&nbsp;is an investigational GalNAc-conjugated RNAi therapeutic targeting PCSK9, a protein regulator of LDL receptor metabolism. In contrast to PCSK9 inhibitors, PCSK9si works by turning off PCSK9 synthesis in the liver.</li><li>Jefferies analyst Biren Amin has raised the price target for MDCO to $49 (38% upside) from $43.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233840\" data-linked=\"Jefferies raises fair value target for The Medicines Company to $49 on Amgen Repatha patent win; shares ahead 8% premarket\" data-tweet=\"$MDCO $MDCO $AMGN - Jefferies raises fair value target for The Medicines Company to $49 on Amgen Repatha patent win; shares ahead 8% premarket https://seekingalpha.com/news/3233840-jefferies-raises-fair-value-target-for-medicines-company-to-49-on-amgen-repatha-patent-win?source=tweet\" data-url=\"https://seekingalpha.com/news/3233840-jefferies-raises-fair-value-target-for-medicines-company-to-49-on-amgen-repatha-patent-win\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233835\" data-ts=\"1483705652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDLS\" target=\"_blank\">NDLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233835-noodles-slips-after-ubs-loses-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noodles slips after UBS loses confidence</a></h4><ul> <li>UBS slaps a Sell rating on Noodles (NASDAQ:<a href='https://seekingalpha.com/symbol/NDLS' title='Noodles & Company'>NDLS</a>) after having the restaurant stock set at Neutral.</li> <li>The investment fimr cuts its price target to $7 from $4 on concerns a recovery won't take hold anytime soon.</li> <li>Shares of Noodles are <font color='red'>down 3.45%</font> premarket to $4.20.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3233835\" data-linked=\"Noodles slips after UBS loses confidence\" data-tweet=\"$NDLS - Noodles slips after UBS loses confidence https://seekingalpha.com/news/3233835-noodles-slips-after-ubs-loses-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3233835-noodles-slips-after-ubs-loses-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233823\" data-ts=\"1483705109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233823-ionis-and-subsidiary-akcea-collaborate-novartis-to-develop-two-cardiovascular-candidates-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ionis and subsidiary Akcea collaborate with Novartis to develop two cardiovascular candidates in deal valued as high as $1.7B; Ionis up 8% premarket</a></h4><ul><li>Ionis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a>) and wholly owned subsidiary Akcea Therapeutics <a href=\"https://seekingalpha.com/pr/16707167-ionis-akcea-enter-strategic-collaboration-global-pharmaceutical-company-develop-commercialize\" target=\"_blank\">ink an exclusive global option and collaboration deal</a> with Novartis (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>) to develop and commercialize AKCEA-APO(a)-Lrx and AKCEA-APOIII-Lrx, two antisense drug candidates to treat lipid disorders.</li><li>Lp(a) is a lipoprotein particle assembled in the liver that is associated with an increased risk of coronary heart disease. ApoC-III is a protein produced in the liver that plays a key role in the regulation of serum triglycerides.</li><li>Ionis and Akcea will conduct a Phase 2 dose-ranging study for each candidate that will inform Phase 3 studies. Prior to the start of Phase 3, Novartis may exercise its option to license and commercialize each drug.</li><li>Under the terms of the agreement, Ionis and Akcea will receive a $75M upfront option payment, a $150M license fee for each drug, up to $315M in development and regulatory milestones for AKCEA-APO(a)Lrx, up to $265M in regulatory and development milestones for AKCEA-APOIII-Lrx and up to $285M and $265M, respectively, in commercial milestones. Novartis will invest $100M in Ionis via the purchase of 1,631,435 shares of common stock at $61.30 upfront and an additional $50M investment in the next 18 months either in IONS or Akcea.</li><li>Management will host a conference call this morning at 9:30 am ET to discuss the deal.</li><li>IONS closed yesterday at $47.09. Shares are up&nbsp;<font color='green'>8%</font>&nbsp;premarket on light volume. NVS is down a fraction on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233823\" data-linked=\"Ionis and subsidiary Akcea collaborate with Novartis to develop two cardiovascular candidates in deal valued as high as $1.7B; Ionis up 8% premarket\" data-tweet=\"$IONS $IONS $NVS - Ionis and subsidiary Akcea collaborate with Novartis to develop two cardiovascular candidates in deal valued as high as $1.7B; Ionis up 8% premarket https://seekingalpha.com/news/3233823-ionis-and-subsidiary-akcea-collaborate-novartis-to-develop-two-cardiovascular-candidates-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3233823-ionis-and-subsidiary-akcea-collaborate-novartis-to-develop-two-cardiovascular-candidates-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233818\" data-ts=\"1483702142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBX\" target=\"_blank\">GBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233818-on-greenbriers-fq1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Greenbrier&#39;s FQ1</a></h4><ul>     <li>Greenbrier (NYSE:<a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a>) reports Manufacturing revenue declined 35% to $454.03M in <a href=\"https://seekingalpha.com/pr/16707196-greenbrier-reports-first-quarter-results\" target=\"_blank\">FQ1</a>.</li>     <li>Wheels &amp; Parts revenue slipped 11.6% to $69.64M.</li>     <li>Leasing &amp; Services revenue grew 14.6% to $28.65M.</li>     <li>Gross margin rate rose 30 bps to 20.4%.</li>     <li>SG&amp;A expense rate expanded 290 bps to 7.5%.</li>     <li>Operating margin rate squeezed 530 bps to 13.2%.</li>     <li>New rail car deliveries -13% Q/Q to 4,000 units.</li>     <li>New railcar manufacturing backlog was 25.8K units valued at $2.97B at quarter's end, vs. 27.5K units valued at $3.19B as of Aug. 31.</li>     <li><b>FY2017 Guidance</b>: Deliveries: ~14,000 to 16,000 units; Revenues: $2B to $2.4B; Diluted EPS: $3.25 to $3.75.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233818\" data-linked=\"More on Greenbrier&#39;s FQ1\" data-tweet=\"$GBX - More on Greenbrier&#39;s FQ1 https://seekingalpha.com/news/3233818-on-greenbriers-fq1?source=tweet\" data-url=\"https://seekingalpha.com/news/3233818-on-greenbriers-fq1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:29 AM </div></div></li>","count":58,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}